Joanna Wiensch
Stock Analyst at Citigroup
(2.60)
# 2,076
Out of 4,783 analysts
29
Total ratings
70%
Success rate
8.23%
Average return
Main Sectors:
Stocks Rated by Joanna Wiensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Upgrades: Buy | $255 → $275 | $228.71 | +20.24% | 5 | Oct 1, 2024 | |
| ABT Abbott Laboratories | Maintains: Buy | $119 → $127 | $131.35 | -3.31% | 8 | Aug 22, 2024 | |
| NVRO Nevro | Downgrades: Neutral | $40 | $5.84 | +584.93% | 1 | Jan 17, 2023 | |
| DXCM DexCom | Maintains: Buy | $83 → $90 | $69.47 | +29.91% | 2 | Apr 29, 2020 | |
| COO The Cooper Companies | Maintains: Neutral | $90 → $80 | $84.98 | -6.45% | 2 | Mar 27, 2020 | |
| IRTC iRhythm Technologies | Initiates: Buy | $120 | $106.11 | +13.09% | 1 | Mar 5, 2020 | |
| PEN Penumbra | Initiates: Buy | $200 | $269.62 | -25.82% | 1 | Mar 5, 2020 | |
| GKOS Glaukos | Initiates: Sell | $40 | $103.62 | -61.40% | 1 | Mar 5, 2020 | |
| ZBH Zimmer Biomet Holdings | Initiates: Buy | $168 | $112.15 | +49.80% | 1 | Mar 5, 2020 | |
| ALC Alcon | Initiates: Neutral | $63 | $96.80 | -34.92% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $235 | $367.54 | -36.06% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $220 | $260.27 | -15.47% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $84 | $71.19 | +17.99% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $94 | $33.70 | +178.93% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $163 | $163.13 | -0.08% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $124 | $88.98 | +39.36% | 1 | Mar 5, 2020 |
Becton, Dickinson and Company
Oct 1, 2024
Upgrades: Buy
Price Target: $255 → $275
Current: $228.71
Upside: +20.24%
Abbott Laboratories
Aug 22, 2024
Maintains: Buy
Price Target: $119 → $127
Current: $131.35
Upside: -3.31%
Nevro
Jan 17, 2023
Downgrades: Neutral
Price Target: $40
Current: $5.84
Upside: +584.93%
DexCom
Apr 29, 2020
Maintains: Buy
Price Target: $83 → $90
Current: $69.47
Upside: +29.91%
The Cooper Companies
Mar 27, 2020
Maintains: Neutral
Price Target: $90 → $80
Current: $84.98
Upside: -6.45%
iRhythm Technologies
Mar 5, 2020
Initiates: Buy
Price Target: $120
Current: $106.11
Upside: +13.09%
Penumbra
Mar 5, 2020
Initiates: Buy
Price Target: $200
Current: $269.62
Upside: -25.82%
Glaukos
Mar 5, 2020
Initiates: Sell
Price Target: $40
Current: $103.62
Upside: -61.40%
Zimmer Biomet Holdings
Mar 5, 2020
Initiates: Buy
Price Target: $168
Current: $112.15
Upside: +49.80%
Alcon
Mar 5, 2020
Initiates: Neutral
Price Target: $63
Current: $96.80
Upside: -34.92%
Mar 5, 2020
Initiates: Buy
Price Target: $235
Current: $367.54
Upside: -36.06%
Mar 5, 2020
Initiates: Buy
Price Target: $220
Current: $260.27
Upside: -15.47%
Mar 5, 2020
Initiates: Buy
Price Target: $84
Current: $71.19
Upside: +17.99%
Mar 5, 2020
Initiates: Neutral
Price Target: $94
Current: $33.70
Upside: +178.93%
Mar 5, 2020
Initiates: Buy
Price Target: $163
Current: $163.13
Upside: -0.08%
Mar 5, 2020
Initiates: Buy
Price Target: $124
Current: $88.98
Upside: +39.36%